贝达基林诱导的异性肺炎在治疗不耐药的mycobacterium avium复合体 (MAC) 肺部疾病中
Irfan Shafiq1, Said Isse2, Zaid Zoumot2
1Cleveland Clinic Abu Dhabi, Abu Dhabi, Abu Dhabi, UAE shafiqi@ccad.ae.
BMJ case reports
|November 26, 2025
概括
贝达奎林用于非结核性菌根菌感染,可以引起异性肺炎,一种罕见的肺反应. 这一案例强调了在服用这种药物的患者中监测新的呼吸道症状和埃索诺菲利亚.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 贝达基林是治疗多抗药结核病的关键药物,越来越多地用于非结核性真菌菌菌 (NTM) 感染.
- 虽然一般耐受性很好,但潜在的不良反应,特别是肺部过敏反应,尚未得到充分证实.
- 贝达基林的使用不断扩大,需要全面了解其安全性概况,而不仅仅是其主要的适应症.
研究的目的:
- 报告第一个已知由贝达基林引起的异性肺炎病例.
- 提高关于贝达奎林这种新型不良影响的临床意识.
- 强调在贝达基林治疗期间表现出相关症状的患者考虑异性肺炎的重要性.
主要方法:
- 病例报告详细介绍了一名患有呼吸系统症状和外围好色素症的患者.
- 对疑似药物诱导的肺损伤进行临床评估,诊断工作和治疗启动.
- 对贝达基林副作用和肺过敏反应现有文献的综述.
主要成果:
- 这名患者出现了新出现的呼吸道症状,并确认了外围好症.
- 诊断出埃索诺菲尔性肺炎,并被认为是贝达基林治疗的次要原因.
- 停用贝达基林和适当的管理导致症状的消失.
结论:
- 这一病例代表了第一个被记录的贝达基林诱导的异性肺炎.
- 临床医生应在接受贝达基林治疗的患者中保持对埃索诺菲尔性肺炎的高度怀疑指数,这些患者会出现呼吸系统症状和埃索诺菲利症.
- 早期识别和管理对于预防与这种不良药物反应相关的严重肺部并发症至关重要.
相关概念视频
Pulmonary Tuberculosis V
530
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
530
Pulmonary Tuberculosis IV
469
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
469
Pulmonary Tuberculosis II
1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pneumonia IV: Management
735
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
735
Pulmonary Tuberculosis I
811
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
811
Pulmonary Tuberculosis III
901
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
901


